PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportstrophoblastic neoplasms
MeSH D014328 - trophoblastic neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D011252:Neoplastic pregnancy complications
0 Companies
0 Drugs
Success rate
D009373:Germ cell and embryonal neoplasms
18 Companies
1 Drug
$
Success rate
D014328: 
Trophoblastic neoplasms
14 Companies
1 Drug
$
Success rate
D002822:Choriocarcinoma
36 Companies
5 Drugs
$
Success rate
D031901:Gestational trophoblastic disease
9 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaEtoposide Etoposide  1994-02-10   
Etoposide Toposar  1995-02-27   
MylanEtoposide Etoposide  2001-09-19   
HospiraEtoposide Etoposide  1995-08-30   
Strides Pharma GlobalEtoposide Vepesid  1986-12-30   
Bristol Myers SquibbEtoposide Etopophos  1998-02-27   
Accord HealthcareEtoposide Etoposide  1996-03-14   
Hikma PharmaceuticalsEtoposide Etoposide  1995-07-17   
CHEPLAPHARM ArzneimittelEtoposide Etopophos  1996-05-17   
CordenPharmaEtoposide Vepesid  1983-11-10   
Fresenius KabiEtoposide Etoposide  1998-09-30   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
4%
1/26
Phase 3
9%
1/11
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Etoposide,
Etoposide phosphate
Bristol Myers Squibb
Etoposide,
Etoposide phosphate
Laboratoires Pierre Fabre
Etoposide,
Etoposide phosphate
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use